Published in Proteomics on July 01, 2010
Deep proteome coverage based on ribosome profiling aids mass spectrometry-based protein and peptide discovery and provides evidence of alternative translation products and near-cognate translation initiation events. Mol Cell Proteomics (2013) 1.33
Lamin A/C is expressed in pluripotent mouse embryonic stem cells. Nucleus (2013) 1.18
Overview: the maturing of proteomics in cardiovascular research. Circ Res (2011) 0.95
Divide and conquer: the application of organelle proteomics to heart failure. Circ Res (2011) 0.94
Systems proteomics for translational network medicine. Circ Cardiovasc Genet (2012) 0.85
DNA and chromatin modification networks distinguish stem cell pluripotent ground states. Mol Cell Proteomics (2012) 0.81
Pluripotent stem cell heterogeneity and the evolving role of proteomic technologies in stem cell biology. Proteomics (2011) 0.80
Establishment of a proteome profile and identification of molecular markers for mouse spermatogonial stem cells. J Cell Mol Med (2014) 0.75
Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem (2002) 35.30
A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem (2003) 29.58
The International Protein Index: an integrated database for proteomics experiments. Proteomics (2004) 14.67
An extended transcriptional network for pluripotency of embryonic stem cells. Cell (2008) 14.64
A protein interaction network for pluripotency of embryonic stem cells. Nature (2006) 9.63
A guide to the Proteomics Identifications Database proteomics data repository. Proteomics (2009) 5.63
Regulatory networks define phenotypic classes of human stem cell lines. Nature (2008) 4.98
Stable isotope labeling by amino acids in cell culture (SILAC) and proteome quantitation of mouse embryonic stem cells to a depth of 5,111 proteins. Mol Cell Proteomics (2007) 3.60
Structural basis for tumor pyruvate kinase M2 allosteric regulation and catalysis. Biochemistry (2005) 3.57
PRIDE Converter: making proteomics data-sharing easy. Nat Biotechnol (2009) 3.22
Pyruvate kinase isozyme type M2 (PKM2) interacts and cooperates with Oct-4 in regulating transcription. Int J Biochem Cell Biol (2007) 1.88
Alternative splicing in the differentiation of human embryonic stem cells into cardiac precursors. PLoS Comput Biol (2009) 1.57
Prediction of membrane protein topology utilizing multiple sequence alignments. J Protein Chem (1997) 1.56
The transcriptional network controlling pluripotency in ES cells. Cold Spring Harb Symp Quant Biol (2008) 1.41
ABRF-PRG04: differentiation of protein isoforms. J Biomol Tech (2007) 1.22
The transcription factor Zfp281 controls embryonic stem cell pluripotency by direct activation and repression of target genes. Stem Cells (2008) 1.16
Identification of prostate-specific antigen (PSA) isoforms in complex biological samples utilizing complementary platforms. J Proteomics (2010) 0.94
Two-dimensional gel electrophoresis database of murine R1 embryonic stem cells. Proteomics (2004) 0.89
c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature (2009) 13.28
HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab (2006) 13.22
Guidelines for the next 10 years of proteomics. Proteomics (2006) 3.61
Embryonic stem cells: prospects for developmental biology and cell therapy. Physiol Rev (2005) 3.27
AGEMAP: a gene expression database for aging in mice. PLoS Genet (2007) 3.22
Clinical proteomics: A need to define the field and to begin to set adequate standards. Proteomics Clin Appl (2007) 2.84
Circulating transforming growth factor-beta in Marfan syndrome. Circulation (2009) 2.69
Cytoprotective role of Ca2+- activated K+ channels in the cardiac inner mitochondrial membrane. Science (2002) 2.23
Proteomic analysis of pharmacological preconditioning: novel protein targets converge to mitochondrial metabolism pathways. Circ Res (2006) 2.20
Uromodulin levels associate with a common UMOD variant and risk for incident CKD. J Am Soc Nephrol (2009) 2.10
Multiple reaction monitoring to identify site-specific troponin I phosphorylated residues in the failing human heart. Circulation (2012) 2.05
Tyrosine 23 phosphorylation-dependent cell-surface localization of annexin A2 is required for invasion and metastases of pancreatic cancer. PLoS One (2011) 1.79
Cardiac ryanodine receptors control heart rate and rhythmicity in adult mice. Cardiovasc Res (2012) 1.77
Transcriptome analysis of mouse stem cells and early embryos. PLoS Biol (2003) 1.75
Characterization of the cardiac myosin binding protein-C phosphoproteome in healthy and failing human hearts. J Mol Cell Cardiol (2013) 1.75
Investigation of an albumin-enriched fraction of human serum and its albuminome. Proteomics Clin Appl (2007) 1.68
Stunned peri-infarct canine myocardium is characterized by degradation of troponin T, not troponin I. Cardiovasc Res (2004) 1.65
Comparison of multiplex immunoassay platforms. Clin Chem (2009) 1.61
Expanding the subproteome of the inner mitochondria using protein separation technologies: one- and two-dimensional liquid chromatography and two-dimensional gel electrophoresis. Mol Cell Proteomics (2006) 1.48
Identification and quantification of S-nitrosylation by cysteine reactive tandem mass tag switch assay. Mol Cell Proteomics (2011) 1.40
Ultrastructure and regulation of lateralized connexin43 in the failing heart. Circ Res (2010) 1.40
Ca(2+) -stimulated basal adenylyl cyclase activity localization in membrane lipid microdomains of cardiac sinoatrial nodal pacemaker cells. J Biol Chem (2008) 1.40
Identification and functionality of proteomes secreted by rat cardiac stem cells and neonatal cardiomyocytes. Proteomics (2010) 1.38
p21-activated kinase increases the calcium sensitivity of rat triton-skinned cardiac muscle fiber bundles via a mechanism potentially involving novel phosphorylation of troponin I. Circ Res (2002) 1.37
Somatic stem cell marker prominin-1/CD133 is expressed in embryonic stem cell-derived progenitors. Stem Cells (2005) 1.36
Recent advances in understanding Marfan syndrome: should we now treat surgical patients with losartan? J Thorac Cardiovasc Surg (2008) 1.35
Multiplex assays for biomarker research and clinical application: translational science coming of age. Proteomics Clin Appl (2010) 1.35
Distinct roles of microRNA-1 and -499 in ventricular specification and functional maturation of human embryonic stem cell-derived cardiomyocytes. PLoS One (2011) 1.34
Modulation of mitochondrial proteome and improved mitochondrial function by biventricular pacing of dyssynchronous failing hearts. Circ Cardiovasc Genet (2009) 1.32
Redox regulation of mitochondrial ATP synthase: implications for cardiac resynchronization therapy. Circ Res (2011) 1.32
B-MYB is essential for normal cell cycle progression and chromosomal stability of embryonic stem cells. PLoS One (2008) 1.32
Crucial role of the sarcoplasmic reticulum in the developmental regulation of Ca2+ transients and contraction in cardiomyocytes derived from embryonic stem cells. FASEB J (2005) 1.26
Can transcriptome size be estimated from SAGE catalogs? Bioinformatics (2003) 1.25
The Human Eye Proteome Project: perspectives on an emerging proteome. Proteomics (2013) 1.23
Abl tyrosine kinase phosphorylates nonmuscle Myosin light chain kinase to regulate endothelial barrier function. Mol Biol Cell (2010) 1.23
Multidimensional liquid chromatography separation of intact proteins by chromatographic focusing and reversed phase of the human serum proteome: optimization and protein database. Mol Cell Proteomics (2005) 1.23
The ryanodine receptor modulates the spontaneous beating rate of cardiomyocytes during development. Proc Natl Acad Sci U S A (2002) 1.23
Strategy for analysis of cardiac troponins in biological samples with a combination of affinity chromatography and mass spectrometry. Clin Chem (2003) 1.22
Site-mapping of in vitro S-nitrosation in cardiac mitochondria: implications for cardioprotection. Mol Cell Proteomics (2010) 1.21
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is pyruvylated during 3-bromopyruvate mediated cancer cell death. Anticancer Res (2009) 1.19
Cysteine oxidative posttranslational modifications: emerging regulation in the cardiovascular system. Circ Res (2013) 1.19
Pulseless electric activity: definition, causes, mechanisms, management, and research priorities for the next decade: report from a National Heart, Lung, and Blood Institute workshop. Circulation (2013) 1.18
A robust, streamlined, and reproducible method for proteomic analysis of serum by delipidation, albumin and IgG depletion, and two-dimensional gel electrophoresis. Proteomics (2005) 1.18
The mouse C2C12 myoblast cell surface N-linked glycoproteome: identification, glycosite occupancy, and membrane orientation. Mol Cell Proteomics (2009) 1.16
Discovering robust protein biomarkers for disease from relative expression reversals in 2-D DIGE data. Proteomics (2007) 1.15
Cardiomyocytes purified from differentiated embryonic stem cells exhibit characteristics of early chamber myocardium. J Mol Cell Cardiol (2003) 1.14
C-terminal truncation of cardiac troponin I causes divergent effects on ATPase and force: implications for the pathophysiology of myocardial stunning. Circ Res (2003) 1.13
A mighty small heart: the cardiac proteome of adult Drosophila melanogaster. PLoS One (2011) 1.13
Quantitative proteomics analysis of human endothelial cell membrane rafts: evidence of MARCKS and MRP regulation in the sphingosine 1-phosphate-induced barrier enhancement. Mol Cell Proteomics (2007) 1.13
The C terminus of cardiac troponin I stabilizes the Ca2+-activated state of tropomyosin on actin filaments. Circ Res (2009) 1.11
Effective removal of albumin from serum. Proteomics (2005) 1.11
SAGE identification of gene transcripts with profiles unique to pluripotent mouse R1 embryonic stem cells. Genomics (2002) 1.08
Identifying patients at high risk of a cardiovascular event in the near future: current status and future directions: report of a national heart, lung, and blood institute working group. Circulation (2010) 1.07
National Heart, Lung, And Blood Institute Clinical Proteomics Working Group report. Circulation (2004) 1.07
Targets of c-Jun NH(2)-terminal kinase 2-mediated tumor growth regulation revealed by serial analysis of gene expression. Cancer Res (2002) 1.07
Proteomics and heart disease: identifying biomarkers of clinical utility. Expert Rev Proteomics (2006) 1.06
SAGE identification of differentiation responsive genes in P19 embryonic cells induced to form cardiomyocytes in vitro. Mech Dev (2002) 1.05
Assessment of albumin removal from an immunoaffinity spin column: critical implications for proteomic examination of the albuminome and albumin-depleted samples. Proteomics (2009) 1.05
Plasma glial fibrillary acidic protein levels in children with sickle cell disease. Am J Hematol (2011) 1.03
A quantitative and validated SAGE transcriptome reference for adult mouse heart. Genomics (2002) 1.03
Biomarker discovery: proteome fractionation and separation in biological samples. Physiol Genomics (2007) 1.03
Physical developmental cues for the maturation of human pluripotent stem cell-derived cardiomyocytes. Stem Cell Res Ther (2014) 1.03
A small nonerythropoietic helix B surface peptide based upon erythropoietin structure is cardioprotective against ischemic myocardial damage. Mol Med (2010) 1.02
Application of reversed phase high performance liquid chromatography for subproteomic analysis of cardiac muscle. Proteomics (2002) 1.02
Nitroxyl-mediated disulfide bond formation between cardiac myofilament cysteines enhances contractile function. Circ Res (2012) 1.02
Preparation of proteins and peptides for mass spectrometry analysis in a bottom-up proteomics workflow. Curr Protoc Mol Biol (2009) 1.02
Electrophysiological and contractile function of cardiomyocytes derived from human embryonic stem cells. Prog Biophys Mol Biol (2012) 1.00
Mechanisms of gap junction traffic in health and disease. J Cardiovasc Pharmacol (2009) 1.00
Mitochondrial proteomics. Undercover in the lipid bilayer. Basic Res Cardiol (2003) 1.00
Rhythmic beating of stem cell-derived cardiac cells requires dynamic coupling of electrophysiology and Ca cycling. J Mol Cell Cardiol (2010) 0.99
WNT-conditioned media differentially affect the proliferation and differentiation of cord blood-derived CD133+ cells in vitro. Differentiation (2007) 0.99
Secreted proteins as a fundamental source for biomarker discovery. Proteomics (2012) 0.98
Optimization of paper bridge loading for 2-DE analysis in the basic pH region: application to the mitochondrial subproteome. Proteomics (2006) 0.98
Pluripotency of embryonic stem cells. Cell Tissue Res (2007) 0.98
Nitration of tyrosine 92 mediates the activation of rat microsomal glutathione s-transferase by peroxynitrite. J Biol Chem (2005) 0.97
Phosphorylation of the F(1)F(o) ATP synthase beta subunit: functional and structural consequences assessed in a model system. Circ Res (2009) 0.97
Developmental cues for the maturation of metabolic, electrophysiological and calcium handling properties of human pluripotent stem cell-derived cardiomyocytes. Stem Cell Res Ther (2014) 0.96
Improvements in two-dimensional gel electrophoresis by utilizing a low cost "in-house" neutral pH sodium dodecyl sulfate-polyacrylamide gel electrophoresis system. Proteomics (2005) 0.96
Developing the next generation of cardiac markers: disease-induced modifications of troponin I. Prog Cardiovasc Dis (2005) 0.95
Subfractionation of heart tissue: the "in sequence" myofilament protein extraction of myocardial tissue. Methods Mol Biol (2007) 0.94
Enhanced proliferation of monolayer cultures of embryonic stem (ES) cell-derived cardiomyocytes following acute loss of retinoblastoma. PLoS One (2008) 0.94
Divide and conquer: the application of organelle proteomics to heart failure. Circ Res (2011) 0.94
Cardiomyogenic stem and progenitor cell plasticity and the dissection of cardiopoiesis. J Mol Cell Cardiol (2008) 0.94
Embryonic stem cells and cardiomyocyte differentiation: phenotypic and molecular analyses. J Cell Mol Med (2005) 0.94
A cell surfaceome map for immunophenotyping and sorting pluripotent stem cells. Mol Cell Proteomics (2012) 0.94
Clinical utility of insulin-like growth factor 1 and 2; determination by high resolution mass spectrometry. PLoS One (2012) 0.93
Redox signaling and protein phosphorylation in mitochondria: progress and prospects. J Bioenerg Biomembr (2009) 0.93